Nationwide Fund Advisors’s Corvus Pharmaceuticals CRVS Stock Holding History

Nationwide Fund Advisors’s Portfolio CRVS Stock Details CRVS Fund Activity

Upgrade to unlock

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q4	–	Sell
2017 Q3	$1.19M	Sell
2017 Q2	$929K	Buy
2017 Q1	$415K	Sell
2016 Q4	$337K	Sell
2016 Q3	$404K	Sell
2016 Q2	$386K	Buy